Selected research
Market Structure
Global Polymerase Chain Reaction (PCR) Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Polymerase Chain Reaction (PCR) Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Polymerase Chain Reaction (PCR) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Polymerase Chain Reaction (PCR) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Polymerase Chain Reaction (PCR) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Polymerase Chain Reaction (PCR) Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Polymerase Chain Reaction (PCR) Devices include Abbott, Stryker, Thermo Fisher Scientific, Smith+Nephew, Siemens, QIAGEN, Merck KGaA, Johnson & Johnson Private Limited and Fluidigm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Polymerase Chain Reaction (PCR) Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Polymerase Chain Reaction (PCR) Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Polymerase Chain Reaction (PCR) Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polymerase Chain Reaction (PCR) Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Polymerase Chain Reaction (PCR) Devices Segment by Company
Abbott
Stryker
Thermo Fisher Scientific
Smith+Nephew
Siemens
QIAGEN
Merck KGaA
Johnson & Johnson Private Limited
Fluidigm
Danaher
Cytiva
Bruker
Bio-Rad Laboratories
bioMérieux
BD
Agilent Technologies
Polymerase Chain Reaction (PCR) Devices Segment by Type
Digital PCR
Real-time PCR
Polymerase Chain Reaction (PCR) Devices Segment by Application
Pharmaceutical and Biotechnology Companies
Diagnostic Center
Hospital
Laboratories
Clinical Research Organizations
Polymerase Chain Reaction (PCR) Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymerase Chain Reaction (PCR) Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymerase Chain Reaction (PCR) Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymerase Chain Reaction (PCR) Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Polymerase Chain Reaction (PCR) Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polymerase Chain Reaction (PCR) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polymerase Chain Reaction (PCR) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Polymerase Chain Reaction (PCR) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Digital PCR
- Real-time PCR
Applications
- Pharmaceutical and Biotechnology Companies
- Diagnostic Center
- Hospital
- Laboratories
- Clinical Research Organizations
Companies covered
- Abbott
- Stryker
- Thermo Fisher Scientific
- Smith+Nephew
- Siemens
- QIAGEN
- Merck KGaA
- Johnson & Johnson Private Limited
- Fluidigm
- Danaher
- Cytiva
- Bruker
- Bio-Rad Laboratories
- bioMérieux
- BD
- Agilent Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Polymerase Chain Reaction (PCR) Devices Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Polymerase Chain Reaction (PCR) Devices Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Polymerase Chain Reaction (PCR) Devices Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Polymerase Chain Reaction (PCR) Devices Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Polymerase Chain Reaction (PCR) Devices Market Dynamics
- 2.1 Polymerase Chain Reaction (PCR) Devices Industry Trends
- 2.2 Polymerase Chain Reaction (PCR) Devices Industry Drivers
- 2.3 Polymerase Chain Reaction (PCR) Devices Industry Opportunities and Challenges
- 2.4 Polymerase Chain Reaction (PCR) Devices Industry Restraints
3 Polymerase Chain Reaction (PCR) Devices Market by Manufacturers
- 3.1 Global Polymerase Chain Reaction (PCR) Devices Revenue by Manufacturers (2021-2026)
- 3.2 Global Polymerase Chain Reaction (PCR) Devices Sales by Manufacturers (2021-2026)
- 3.3 Global Polymerase Chain Reaction (PCR) Devices Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Polymerase Chain Reaction (PCR) Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Polymerase Chain Reaction (PCR) Devices Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Polymerase Chain Reaction (PCR) Devices Manufacturers, Product Type & Application
- 3.7 Global Polymerase Chain Reaction (PCR) Devices Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Polymerase Chain Reaction (PCR) Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Polymerase Chain Reaction (PCR) Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Polymerase Chain Reaction (PCR) Devices Tier 1, Tier 2, and Tier 3
4 Polymerase Chain Reaction (PCR) Devices Market by Type
- 4.1 Polymerase Chain Reaction (PCR) Devices Type Introduction
- 4.1.1 Digital PCR
- 4.1.2 Real-time PCR
- 4.2 Global Polymerase Chain Reaction (PCR) Devices Sales by Type
- 4.2.1 Global Polymerase Chain Reaction (PCR) Devices Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Polymerase Chain Reaction (PCR) Devices Sales by Type (2021-2032)
- 4.2.3 Global Polymerase Chain Reaction (PCR) Devices Sales Market Share by Type (2021-2032)
- 4.3 Global Polymerase Chain Reaction (PCR) Devices Revenue by Type
- 4.3.1 Global Polymerase Chain Reaction (PCR) Devices Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Polymerase Chain Reaction (PCR) Devices Revenue by Type (2021-2032)
- 4.3.3 Global Polymerase Chain Reaction (PCR) Devices Revenue Market Share by Type (2021-2032)
5 Polymerase Chain Reaction (PCR) Devices Market by Application
- 5.1 Polymerase Chain Reaction (PCR) Devices Application Introduction
- 5.1.1 Pharmaceutical and Biotechnology Companies
- 5.1.2 Diagnostic Center
- 5.1.3 Hospital
- 5.1.4 Laboratories
- 5.1.5 Clinical Research Organizations
- 5.2 Global Polymerase Chain Reaction (PCR) Devices Sales by Application
- 5.2.1 Global Polymerase Chain Reaction (PCR) Devices Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Polymerase Chain Reaction (PCR) Devices Sales by Application (2021-2032)
- 5.2.3 Global Polymerase Chain Reaction (PCR) Devices Sales Market Share by Application (2021-2032)
- 5.3 Global Polymerase Chain Reaction (PCR) Devices Revenue by Application
- 5.3.1 Global Polymerase Chain Reaction (PCR) Devices Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Polymerase Chain Reaction (PCR) Devices Revenue by Application (2021-2032)
- 5.3.3 Global Polymerase Chain Reaction (PCR) Devices Revenue Market Share by Application (2021-2032)
6 Global Polymerase Chain Reaction (PCR) Devices Sales by Region
- 6.1 Global Polymerase Chain Reaction (PCR) Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Polymerase Chain Reaction (PCR) Devices Sales by Region (2021-2032)
- 6.2.1 Global Polymerase Chain Reaction (PCR) Devices Sales by Region (2021-2026)
- 6.2.2 Global Polymerase Chain Reaction (PCR) Devices Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Polymerase Chain Reaction (PCR) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Polymerase Chain Reaction (PCR) Devices Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Polymerase Chain Reaction (PCR) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Polymerase Chain Reaction (PCR) Devices Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Polymerase Chain Reaction (PCR) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Polymerase Chain Reaction (PCR) Devices Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Polymerase Chain Reaction (PCR) Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Polymerase Chain Reaction (PCR) Devices Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Polymerase Chain Reaction (PCR) Devices Revenue by Region
- 7.1 Global Polymerase Chain Reaction (PCR) Devices Revenue by Region
- 7.1.1 Global Polymerase Chain Reaction (PCR) Devices Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Polymerase Chain Reaction (PCR) Devices Revenue by Region (2021-2026)
- 7.1.3 Global Polymerase Chain Reaction (PCR) Devices Revenue by Region (2027-2032)
- 7.1.4 Global Polymerase Chain Reaction (PCR) Devices Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Polymerase Chain Reaction (PCR) Devices Revenue (2021-2032)
- 7.2.2 North America Polymerase Chain Reaction (PCR) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Polymerase Chain Reaction (PCR) Devices Revenue (2021-2032)
- 7.3.2 Europe Polymerase Chain Reaction (PCR) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Polymerase Chain Reaction (PCR) Devices Revenue (2021-2032)
- 7.4.2 Asia-Pacific Polymerase Chain Reaction (PCR) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Polymerase Chain Reaction (PCR) Devices Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Polymerase Chain Reaction (PCR) Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Stryker
- 8.2.1 Stryker Company Information
- 8.2.2 Stryker Business Overview
- 8.2.3 Stryker Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Stryker Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.2.5 Stryker Recent Developments
- 8.3 Thermo Fisher Scientific
- 8.3.1 Thermo Fisher Scientific Company Information
- 8.3.2 Thermo Fisher Scientific Business Overview
- 8.3.3 Thermo Fisher Scientific Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Thermo Fisher Scientific Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.3.5 Thermo Fisher Scientific Recent Developments
- 8.4 Smith+Nephew
- 8.4.1 Smith+Nephew Company Information
- 8.4.2 Smith+Nephew Business Overview
- 8.4.3 Smith+Nephew Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Smith+Nephew Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.4.5 Smith+Nephew Recent Developments
- 8.5 Siemens
- 8.5.1 Siemens Company Information
- 8.5.2 Siemens Business Overview
- 8.5.3 Siemens Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Siemens Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.5.5 Siemens Recent Developments
- 8.6 QIAGEN
- 8.6.1 QIAGEN Company Information
- 8.6.2 QIAGEN Business Overview
- 8.6.3 QIAGEN Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 QIAGEN Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.6.5 QIAGEN Recent Developments
- 8.7 Merck KGaA
- 8.7.1 Merck KGaA Company Information
- 8.7.2 Merck KGaA Business Overview
- 8.7.3 Merck KGaA Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Merck KGaA Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.7.5 Merck KGaA Recent Developments
- 8.8 Johnson & Johnson Private Limited
- 8.8.1 Johnson & Johnson Private Limited Company Information
- 8.8.2 Johnson & Johnson Private Limited Business Overview
- 8.8.3 Johnson & Johnson Private Limited Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Johnson & Johnson Private Limited Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.8.5 Johnson & Johnson Private Limited Recent Developments
- 8.9 Fluidigm
- 8.9.1 Fluidigm Company Information
- 8.9.2 Fluidigm Business Overview
- 8.9.3 Fluidigm Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Fluidigm Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.9.5 Fluidigm Recent Developments
- 8.10 Danaher
- 8.10.1 Danaher Company Information
- 8.10.2 Danaher Business Overview
- 8.10.3 Danaher Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Danaher Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.10.5 Danaher Recent Developments
- 8.11 Cytiva
- 8.11.1 Cytiva Company Information
- 8.11.2 Cytiva Business Overview
- 8.11.3 Cytiva Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Cytiva Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.11.5 Cytiva Recent Developments
- 8.12 Bruker
- 8.12.1 Bruker Company Information
- 8.12.2 Bruker Business Overview
- 8.12.3 Bruker Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Bruker Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.12.5 Bruker Recent Developments
- 8.13 Bio-Rad Laboratories
- 8.13.1 Bio-Rad Laboratories Company Information
- 8.13.2 Bio-Rad Laboratories Business Overview
- 8.13.3 Bio-Rad Laboratories Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bio-Rad Laboratories Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.13.5 Bio-Rad Laboratories Recent Developments
- 8.14 bioMérieux
- 8.14.1 bioMérieux Company Information
- 8.14.2 bioMérieux Business Overview
- 8.14.3 bioMérieux Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 bioMérieux Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.14.5 bioMérieux Recent Developments
- 8.15 BD
- 8.15.1 BD Company Information
- 8.15.2 BD Business Overview
- 8.15.3 BD Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 BD Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.15.5 BD Recent Developments
- 8.16 Agilent Technologies
- 8.16.1 Agilent Technologies Company Information
- 8.16.2 Agilent Technologies Business Overview
- 8.16.3 Agilent Technologies Polymerase Chain Reaction (PCR) Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Agilent Technologies Polymerase Chain Reaction (PCR) Devices Product Portfolio
- 8.16.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Polymerase Chain Reaction (PCR) Devices Value Chain Analysis
- 9.1.1 Polymerase Chain Reaction (PCR) Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Polymerase Chain Reaction (PCR) Devices Production Mode & Process
- 9.2 Polymerase Chain Reaction (PCR) Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Polymerase Chain Reaction (PCR) Devices Distributors
- 9.2.3 Polymerase Chain Reaction (PCR) Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst